US Blame Game Twist: Suing China for COVID-19 Outbreaks

No evidence suggests that COVID-19 originated in a Chinese lab or from bat-eating Chinese people.

Writer Allen Yu explained that no Chinese tradition of bat-eating exists. Videos suggesting otherwise weren’t from Wuhan or elsewhere in China.

Filming was “in Palau or Indonesia, in locales where bats have traditionally been consumed as food,” said Yu, adding:

The bat-eating theory doesn’t hold up. “According to current research, it is not likely that bat (or other) consumption” of wild animals caused COVID-19.

Researcher Larry Romanoff explained that “Japanese and Taiwanese epidemiologists and pharmacologists have determined that the new coronavirus (COVID-19) almost certainly originated in the US.”

In September 2019, Japanese citizens who never visited China were infected with the novel coronavirus in Hawaii — “long before the outbreak in Wuhan.”

Falsely blaming China for its origination is all about the Trump regime shifting blame for its own wrongdoing and failings onto others.

French virologist/Nobel laureate for Medicine Luc Montagnier said COVID-19 was man-made, not transmitted to humans from bats or other wildlife.

In April, a peer-reviewed study published in the Antiviral Research medical journal revealed unique COVID-19 features that facilitate human-to-human transmission — making the novel coronavirus much more contagious than seasonal flu/influenza.

The study also found no evidence that COVID-19 evolved naturally. Its genetic coding isn’t natural.

Most likely it was engineered with elements from MERS (Middle East Respiratory Syndrome) — first reported in 2012, according to the study.

Genomics researcher James Lyons-Weiler explained that “(t)here is no doubt that there is a novel sequence in 2019-nCoV” —the virus causing COVID-19 disease, adding:

“IPAK researchers found a sequence similarity between a pShuttle-SN recombination vector sequence and INS1378,” indicating human engineering.

Infectious diseases expert Dr. Yuhong Dong explained that “this new coronavirus has unprecedented virologic features that suggest genetic engineering may have been involved in its creation.”

“The virus (has) severe clinical features. Thus it poses a huge threat to humans.”

“It is imperative for scientists, physicians, and people all over the world, including governments and public health authorities, to make every effort to investigate this mysterious and suspicious virus in order to elucidate its origin and to protect the ultimate future of the human race.”

A Lancet report said “recombination is probably not the reason for emergence of this virus” — meaning mutations likely didn’t occur naturally.

Greek scientists found no connection between COVID-19 and viruses occurring naturally, saying:

“(T)he new coronavirus provides a new lineage for almost half of its genome, with no close genetic relationships to other viruses within the subgenus of sarbecovirus” — meaning it didn’t occur from natural mutations.

China’s Global Times accused the Trump regime of “international hooliganism” by the following tactics:

Accusing Beijing of initially “concealing” COVID-19 outbreaks, claiming it let the disease spread and “harm the US and the world.”

Claiming China concealed its “actual number of deaths.”

By its actions, the Trump regime fueled anti-China sentiment and encouraged individual and class-action lawsuits — while diverting attention from its own failings.

On March 13, Thailand Medical News (TMN) news reported that “traditional Chinese medicine concoctions used alone or in conjunction with antiviral protocols (is the) secret to (its success in) controlling…COVID-19 outbreaks.”

A peer-reviewed Lancet study of 102 Chinese COVID-19 infected patients treated by the above protocol showed nearly all recovered.

Another study of 701 confirmed COVID-19 infected patients showed that over 90% were cured, had improved symptoms, or were stable with no further deterioration when treated withe above protocol.

China is in the forefront of combatting COVID-19, the US a laggard for failing to prepare for what its officials knew was possible long in advance of outbreaks, and failing to provide proper help to states, local communities, and ordinary Americans in need.

The Journal of the American Medical Association (JAMA) said “minimal diagnostic” testing for weeks after outbreaks began contributed to their spread, adding:

Faulty test kits produced inconclusive or invalid results, making a bad situation worse.

The proof of the pudding is in the data. The US by far leads the world in COVID-19 outbreaks (around 700,000 through Friday), deaths (about 37,000), and mishandling of the public health crisis.

The true seriousness of the disease will best be known in hindsight.

Calling it a hoax is a disservice to growing numbers of infected Americans and others abroad.

According to CDC data for April 14, more Americans died from COVID-19 infection than any other cause.

The Trump regime’s blame game, falsely accusing China for originating COVID-19, encouraged multiple class action lawsuits in the US.

Through mid-April, numerous suits were filed against China and other targets, seeking trillions of dollars in compensation.

One filed in late March by California property managers and an accounting firm that represent small businesses seeks compensation from China for what it had nothing to do with.

A Florida class action suit representing millions of state residents seeks to cash in the same way.

Freedom Watch head Larry Klayman leads another anti-China class-action suit that falsely accuses Beijing of unleashing a biological weapon on humanity.

Anti-China lawsuits are highly unlikely to be successful. No evidence suggests Beijing’s responsibility for COVID-19 outbreaks.

According to California attorney Kent Schmidt, numerous class-action suits were filed, adding:

“These early filings can be indicative of the liabilities that companies should take into consideration and inform their practices now to avoid getting hit with one of these costly lawsuits.”

A class-action case was filed against Norwegian Cruise Lines. It alleges that the company made “unproven (and) blatantly false” statements regarding COVID-19 in order to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members.”

Other cruise line companies may face similar lawsuits.

A virtual cottage industry of litigation stems from COVID-19 outbreaks.

A Washington state civic organization sued Fox News for claiming that COVID-19 is a hoax.

Stating an opinion, true or false, doesn’t involve legal liability.

New York Sports Clubs was sued for allegedly defrauding members during the shutdown.

Inovio Pharmaceuticals was sued for allegedly claiming it developed a vaccine for COVID-19.

A union representing state employees sued Alaska for subjecting them to health and safety risks from COVID-19 outbreaks.

Use of Zoom communications telecommuting application risks lawsuits for violating privacy protections. At least one class-action lawsuit already was filed against the company.

Tort lawyers in the US and perhaps elsewhere see COVID-19 outbreaks as a chance to cash in big.

A Final Comment

Republican Senator Josh Hawley introduced the so-called Justice for Victims of COVID-19 Act to hold China responsible for outbreaks.

The measure would strip Beijing of immunity in US court and permit lawsuits against the state and its authorities.

GOP Senator Tom Cotton and Rep. Dan Crenshaw introduced legislation to let US citizens sue China for “damages” caused by COVID-19.

Given anti-China fervor in the US in more normal times, now bordering on hysteria, the measure will likely become the law of the land.

The so-called Immunities Act protects foreign nations from being sued in US courts — except for China.

Enactment of these measures into law will likely produce a greater divide between both countries, making mutual cooperation all the harder.

*

Note to readers: please click the share buttons below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Award-winning author Stephen Lendman lives in Chicago. He can be reached at [email protected]. He is a Research Associate of the Centre for Research on Globalization (CRG)

His new book as editor and contributor is titled “Flashpoint in Ukraine: US Drive for Hegemony Risks WW III.”

http://www.claritypress.com/LendmanIII.html

Visit his blog site at sjlendman.blogspot.com.

Featured image is from Asia Times


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research


Articles by: Stephen Lendman

About the author:

Stephen Lendman lives in Chicago. He can be reached at [email protected]. His new book as editor and contributor is titled "Flashpoint in Ukraine: US Drive for Hegemony Risks WW III." http://www.claritypress.com/LendmanIII.html Visit his blog site at sjlendman.blogspot.com. Listen to cutting-edge discussions with distinguished guests on the Progressive Radio News Hour on the Progressive Radio Network. It airs three times weekly: live on Sundays at 1PM Central time plus two prerecorded archived programs.

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]